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Chromosome I Abnormalities in Cervical Carcinoma 
CHANDRIKA SREEKANTAIAH, PHD,* M. KRISHNA BHARGAVA, MD,* AND N. JAYA SHETTY, PHD,t 
Abnormalities of chromosome 1 have been reported in a number of solid tumors and hematologic malig- 
nancies, indicating that this is a frequent event in neoplasia. Here we report our observations on aberrations 
of chromosome 1 in malignancies of the uterine cervix. Tumor material obtained from 148 patients with 
invasive carcinoma of the cervix and two cases of carcinoma in situ (CIS) was analyzed on direct preparations 
by Gbanding. The results showed abnormalities of chromosome 1 to be one of the most common karyotypic 
changes, with 95% of the patients showing rearrangements of this chromosome. These changes were 
never seen as the sole abnormality but were always found in association with other chromosomal aberrations. 
Numerical rearrangements were present in 54% of the cases, with losses of unaltered chromosome 1 
predominating. Consistent marker chromosomes included deletions of chromosome 1 at bands q32, p34, 
q42, p32, and p22, isochromosomes of both the “p” and “q” arms and translocations, particularly on the 
long arm. Specific regions on both arms of chromosome 1 (lpll-p13 and lq21-q32) were preferentially 
overrepresented in changes involving this chromosome. Certain breakpoints were nonrandomly involved 
in the structural changes, particularly band lq32 breaks occurring at this site in 88 instances. The presence 
of chromosome 1 aberrations in the two cases of CIS suggests that rearrangements of this chromosome 
are not always a secondary change contributing to the progression of the cancer, but also may represent 
an early cytogenetic event as in neuroblastoma, some leukemias, and myeloproliferative disorders. 
Cancer 62:1317-1324, 1988. 
ARKER CHROMOSOMES involving chromosome 1 M are a frequent phenomenon in diverse forms of 
cancer, including the hematologic malignancies. They 
have been associated more often with later stages of cancer 
and are postulated to represent a secondary genetic event 
capable of providing the cells with a proliferative advan- 
tage.’-3 In certain malignancies, however, aberrations of 
chromosome 1 may represent specific initiating changes 
such as deletions of l p  in neuroblastoma~~-~ and mela- 
n o m a ~ , ~ , ~  and translocations involving chromosome 1 and 
chromosomes 3, 7, 17, and 19 in leukemias and myelo- 
dys~lasia.~-’~ 
Chromosome 1 aberrations have been observed in 
preinvasive lesions of the uterine ~erv ix , ’~ , ’~  including the 
carcinoma in situ (CIS) stage that precedes stromal in- 
vasion, possibly suggesting an initiating role. Few banding 
analyses on invasive carcinmomas of the uterine cervix 
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have appeared in the literature. Earlier  report^'^.'^ dem- 
onstrated the consistent involvement of chromosome 1 
in cervical cancers, either as a relative excess of normal 
chromosome 1 (i.e., trisomy) or in one or more structural 
changes. Subsequent studies with have con- 
firmed nonrandom changes involving this chromosome 
in cervical neoplasms. 
In this report, various cytogenetic changes involving 
chromosome 1 in two cases of CIS and 148 cases of in- 
vasive carcinoma of the uterine cervix are described. 
Materials and Methods 
Chromosome preparations were made from biopsy 
material of primary untreated carcinomas of the cervix 
by a method described previously?2 In brief, this consisted 
of disaggregation of the tissue by mincing, colchicine arrest 
(2 &ml) for 30 minutes, hypotonic treatment (0.075 moll 
1 of KC1) for 30 minutes more, and fixation in methanol 
and acetic acid (dilution, 3:l). Slides prepared the next 
day were G-banded by the method of Sumner et al.,23 
and karyotypes were expressed according to the standard 
n~menclature.’~ Although the tumors analyzed contained 
complex chromosome abnormalities involving almost all 
of the chromosomes in the complement, only those ab- 
errations that involved all or part of chromosome 1 are 
considered here. Of the 150 cases, two or more cells were 
karyotypically assessed in 1 19 tumors. Considerable 
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TABLE 1. Structural Rearrangements Involving Chromosome 1 
Marker no. 
No. of 
Abnormality cases Marker no. 
No. of 
Abnormality cases 
Deletions 
M1 
M2 
M3 
M4 
M5 
M6 
M7 
M8 
M9 
M10 
M11 
M12 
M13 
MI4 
MI5 
M16 
MI7 
MI8 
M19 
M20 
M2 1 
M22 
M23 
M24 
M25 
M26 
M27 
M28 
M29 
Inversions 
M30 
M3 1 
M32 
M33 
M34 
M35 
M36 
M37 
M38 
M39 
M40 
M4 1 
M42 
M43 
M44 
del( 1 )(pll) 
deU 1 )(PI 2) 
deU 1 )(P 13) 
deU I ) ( ~ 2  1) 
deU 1 ) ( ~ 2 2 )  
deU 1 ) ( ~ 3  1 ) 
deU 1 ) (~32)  
del( 1)(~33) 
del( 1 ) (~34)  
del( 1 ) (~35)  
deU 1 )(q 1 1) 
deU 1 )(42 1 ) 
deU 1 )(q23) 
deU I h 2 4 )  
deU 1 k 2 5 )  
deU 1 )(q3 1) 
deU I )(q32) 
deU 1 )(q42) 
del( I)(:pl3+q32:) 
del( I)(:p22+q41:) 
del( I)(:p32+q32:) 
del( I)(:p32+q42:) 
del( I)(:p34+q32:) 
del( 1 )(:p34+q42:) 
del( 1 )(:p35+q42:) 
del( I)(:p33+q41:) 
der(l)(qter+cen::q 1 l+q31:) 
der( l)(qter+cen::q I 1 +q32:) 
der( l)(qter+cen::ql l+q41:) 
inv(l)(pl lq21) 
inv( l)(p2 lq22) 
inv(l)(p13q21) 
inv( l)(p22q25) 
inv( l)(p22q42) 
inv( l)(p32q21) 
inv( 1)(p32q23) 
inv( l)(p32q44) 
inv( 1 )(p34q32) 
inv( l)(p34q42) 
inv( l)(p34q44) 
inv( lXp35q42) 
inv( l)(p36q2 1) 
inv( l)(p36q32) 
inv( l)(p36q42) 
22 
2 
16 
4 
29 
3 
32 
3 
45 
2 
6 
4 
4 
4 
3 
2 
58 
42 
I 
2 
8 
2 
3 
3 
1 
1 
2 
1 
2 
1 
1 
1 
1 
2 
1 
3 
1 
4 
1 
1 
1 
1 
9 
2 
Insertions 
M45 
M46 
M47 
M48 
M49 
M50 
M5 1 
M52 
Duplications 
Isochromo- 
somes 
M53 
M54 
M55 
M56 
M57 
M58 
M59 
M60 
M6 1 
M62 
M63 
M64 
M65 
M66 
M67 
M68 
M69 
M70 
M7 1 
M72 
M73 
M74 
M76 
M75, 
M77-M84 
M85 
M89 
M90 
M9 1 
Translocations 
M86-M88 
?dir ins( l)(p13q32q43) 
?dir ins( l)(q21pl lp32) 
?dir ins( l)(q2 lp32p35) 
?inv ins(l)(q21p32pll) 
dir dup(l)(qll+q21) 
dir dup( l)(q2 1 +q44) 
dir dup( l)(q2 1 +q32) 
dir dup( l)(q 1 1 +q42) 
i ( b )  
i (h )  
t(l;2)(~34;q37) 
t(l;2)(q2 1 ;p13) 
t( 1 ;3)(p 1 1 ;p 1 1) 
t(I;3)(pll;qll) 
dic(l;3)(p34;qll) 
t(1;3)(q32;q39) 
t(1;3)(q44;qll) 
t( I ;4)(q2 1 ;pl6) 
t(l;5)(q2 1 ;pl5) 
t( l ;6)(~11;~11) 
t( 1 ; 10)(p2 l;q24) 
t ( l ; l3)(ql l ;pl l )  
t(1;13)(plI;pll) 
t(1;14)(plI;qll) 
t(1;15)(qll;q26) 
t( I ;  16)(q25;q24) 
t(1;17)(p32;qlI) 
t(l;17)(p36;qll) 
t( 1 ; 17)(q42;q I 1) 
dic( 1 ; 18)(q42; pl  1) 
t( l;?)(p32;?) 
t( 1 ;?)(p36;?) 
? tri( i;?;?)(p21;?;?) 
t( l;?)(q44;?) 
dic( l;l)(p32;p32) 
dic( l;l)(p22;q25) 
t( l;?)(p34;?) 
1 
i 
i 
1 
1 
1 
1 
1 
20 
34 
1 
1 
2 
5 
1 
1 
1 
2 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
9 
1 
3 
1 
1 
1 
karyotypic diversity was present in almost all of the 1 19 
cases. Although a clonal change was evident by the pres- 
ence of similar marker chromosomes in more than one 
cell in all the cases studied, extensive variation in karyo- 
types, both within and between cases, was common. In 
cases characterized by a number of marker chromosomes, 
they were observed in all of the cells or in only a portion 
of the cells, the remaining containing a combination of 
the markers. In 17 cases, only one cell could be analyzed 
in detail. In three cases, partial karyotypes were obtained. 
In the remaining 1 1 cases, only chromosome counts were 
possible. 
Results 
Abnormalities of chromosome 1, both numerical and 
structural, represented the most frequent karyotypic 
change among the cervical carcinomas analyzed. All of 
the chromosomes in the set were involved in rearrange- 
ments to varying extents. In addition to chromosome 1, 
those showing nonrandom involvement in marker for- 
mation were chromosomes 6 ,  11, 3, 5, and 17 (in order 
of frequency). Although abnormalities of chromosome 
10 were uncommon, a marker involving this chromo- 
some, del( 10)(q24), along with del( l)(q32) constituted the 
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two most common markers in the series. Numerical rear- 
rangements involved nonrandom losses of chromosomes 
1, 2, and 11,  and specific gains of chromosomes 5 ,  7, 9, 
12, 16, 18, 19,20, and X. Only five of 139 cases in which 
karyotypic data were available did not show either a nu- 
merical or structural change of chromosome 1. Two other 
cases had no structural aberrations of chromosome 1, but 
were monosomic for chromosome 1. 
Numerical changes (loss or gain of an unaltered chro- 
mosome) were present in 54% of the cases, with losses 
predominating. In most instances, the resulting mono- 
somy or nullisomy of chromosome 1 with respect to the 
normal unaltered chromosome 1 was partial due to its 
involvement in structural rearrangements. Up to 11 dif- 
ferent markers of chromosome 1 were present in some 
cases. 
The structural changes included deletions (resulting in 
the formation of 307 markers), isochromosome forma- 
tions (20 of the p arm and 34 of the q arm), 42 translo- 
cations, 30 inversions, four cases of duplication, and four 
tumors with insertions. Ninety one different markers were 
formed by the above mechanisms (Table 1). Sixty percent 
of these marker chromosomes (55 of 9 1) were apparently 
unique (i.e., present in one case only), whereas a number 
of the others were nonrandom changes. 
Deletions 
All were terminal deletions and represented the most 
frequent type of aberration. The 307 deletions involved 
either the short or long arms or both along their entire 
length. The most consistent marker was a deletion of the 
long arm at band q32 in 58 cases (41%) (Fig. 1, part g). 
The other specific marker of the rong arm was del( l)(q42) 
in 42 cases (Fig. 1, part h). On the short arm, deletions 
nonrandomly occurred in bands p34 (n = 4 3 ,  p32 (n 
= 32), p22 (n = 29), p l l  (n = 22), andp13 (n = 16) (Figs. 
1, parts a through e). The other bands were deleted in 
lower frequencies. Deletions involving both arms simul- 
taneously were present in 26 cases, the most common 
being del( l)(:p32-+q32:) in eight cases (Fig. 1, part i). 
Inversions 
Fifteen types of pencentric inversions were recorded in 
30 cases. The most common was an inversion involving 
bands p36 and q32 (inv( l)(p36q32)) in nine cases (Fig. 1, 
part j). The origin of four markers (M45 to M48; Table 
1) was tentatively identified as being due to insertions 
within chromosome 1 itself. 
Duplications 
variable segments of the long arm (Table 1). 
Duplications were present in five cases and involved 
FIG. 1 .  G-banded partial karyotypes of consistent marker chromosomes 
involving chromosome 1.  Arrows indicate the rearranged chromosomes. 
(a) del(l)(pll); (b) del(INp13); (c) deUl)(p22); (d) del(l)(p32); (e) 
deU 1 Xp34); (0 deU 1 )(q 1 1 ); (g) del( 1 )(q32); (h) deU l)(q42); (i) del( 1)- 
(:p32+q32:); (j) inv(l)(p36q32); (k) i( lp); and (1) i(1q). 
Zsochromosomes 
Short arm isochromosomes, i( lp) (Fig. 1, part k), were 
present in 20 cases. Long arm isochromosomes, i( lq) (Fig. 
1, part l), were present in 34 cases. 
Translocat ions 
Forty-two cases showed translocations of chromosome 
1 (Table 1). The participating chromosomes were chro- 
mosomes 2, 3,4, 5,6,  10, 13, 14, 15, 16, 17, and 18 with 
variable breakpoints. The most common translocation 
partner was chromosome 3. Translocations between 
chromosomes 1 and 3 occurred in ten cases, with breaks 
at 1 p 1 1 in seven cases and at 3q 1 1 in six cases. Translo- 
cations of unidentified material were present on the short 
arm in 11 cases and on the long arm in three cases. Di- 
centric chromosomes formed by translocations between 
chromosomes 1 were observed in two cases. 
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An analysis of the breakpoints on chromosomes formed 
by structural rearrangements in the cervical cancers 
showed that certain regions on the chromosomes are more 
prone to aberrations than others. In general, most of the 
breakpoints listed could be grouped into the following 
three areas: (1) lp32-p34 with 117 breaks: (2) lpll-p13 
with 57 breaks; and (3) lq32-q34 with 150 breakpoints. 
A schematic illustration of breakpoints involved in chro- 
mosome 1 aberrations is depicted in Figure 2. A high 
degree of specificity was apparent for a number of bands 
along both the long and short arms. Band lq32 was the 
most frequently involved breakpoint in deletions, inver- 
sions, translocations, and duplications. Breaks occurred 
at this site 88 times. Fifty-nine breaks at band lp34, 57 
breaks at band lq42, and 54 breaks at band lp32 occurred 
predominantly due to deletions. Thirty-seven breaks at 
l p l l ,  36 breaks at lp22, and 25 breaks at lp36 were a 
consequence of deletions, inversions, and translocations. 
Smaller clusters of breaks were observed for bands l p  13 
and lq21 (18 times each), lql  1 and lq25 (eight times 
each), and lq23 and lq44 (seven times each). Of the 1 19 
breaks in the centromeric region (lp12-lq21), 54 were 
involved in the formation of isochromosomes. 
Specific regions of chromosome 1, on both the short 
arm and long arm, were present consistently in the marker 
chromosomes formed. Region 1 p 1 1 - 1 p 1 3 was retained 
in 84% of the rearrangements and region lq21-lq32 in 
94% of the changes. This is illustrated in Figure 3. Each 
FIG. 2. Schematic illustration of 
the sites and frequency of breaks due 
to rearrangements of chromosome 
1. The location of the five oncogenes 
(*), the nine fragile sites (A), and the 
seven nonrandom sites of breakage 
induced by HSV (0) also are indi- 
cated. 
vertical line of Figure 3 represents the abnormalities of 
chromosome 1 (markers M1 to M91; Table 1). The in- 
versions and insertions are represented as lines running 
the length of the chromosome because no loss of chro- 
mosome 1 material occurred in these abnormalities, and 
in some cases, they were present in addition to the normal 
chromosomes 1 or other aberrations of chromosome 1. 
The dashed horizontal lines enclose the specific segments. 
Discussion 
Chromosome 1 is the chromosome most frequently in- 
volved in human cancer and leukemia. Its association 
with the malignant process has been stressed repeatedly. 
Aberrations of this chromosome have been reported in a 
variety of malignancies, including lung, bladder, breast, 
testes, prostate, kidney, colorectum, neuroblastomas, 
malignant melanomas, soft tissue sarcomas, gynecologic 
malignancies, and those of hematologic origin.25 From 
our data and the published literature, numerical and 
structural changes of chromosome 1 constitute the most 
common karyotypic alteration in carcinoma of the cervix 
uterus. Before the introduction of banding, abnormalities 
of chromosome 1 were reported as isochromosomes, ter- 
minal deletions, and translocations of either or both 
With banding, Atkin and Baker reported con- 
sistent involvement of chromosome 1 in structural and 
numerical changes in six of nine near-diploid turn or^'^ 
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FIG. 3. Diagrammatic representation ofthe var- 
ious abnormalities (vertical lines) and the specific 
regions consistently retained in structural aberra- 
tions of chromosome 1 (enclosed by the dashed 
horizontal lines). Region 1 pl1- 1 p 1 3 was involved 
in 84% of the rearrangements and region Iq21- 
lq32 in 94%. 
1 
Deletions 
and seven of ten in the triploid-tetraploid range.20 Iso- 
chromosome of the long arm, deletions of the short arm, 
and translocations with various chromosomes were the 
changes observed. In their analysis, van der Riet-Fox er 
a1." observed structural aberrations of chromosome 1 in 
two of six cervical carcinomas studied. In both instances, 
duplication of the long arm (region q2 1-q32) was noticed. 
One other case had a translocation between chromosomes 
1 and 5,21 with the break on chromosome 1 at q25. 
In this series, deletions of chromosome 1 at various 
bands constituted the most common markers. The most 
frequent marker, del( l)(q32), present in 58 cases (41%), 
also has been reported in both hematologic and solid ma- 
lignancies.26 The other specific marker on the long arm, 
del( l)(q42), found in 42 cases, was seen in primary and 
metastatic cancers of other  site^.'*,^^,^' Markers of the short 
arm, del( l)(p34), del( l)(p32), del( l)(p22), and del( l)(pl I), 
were common to neuroblastomas, lung cancers, lympho- 
mas, and Th e del(l)(pl3) marker 
present in 16 cases was reported by Kakati et ~ 1 . ~ '  in cells 
obtained from the pleural effusion of a breast cancer and 
the ascitic fluid of a patient with ovarian carcinoma. 
Translocations to other chromosomes appear to have 
occurred at random, except to chromosome 3 in ten cases. 
In cervical cancer, translocations have been reported be- 
tween chromosome 1 and chromosomes 3, 4, l l  (two 
cases each), 17, and 19 (one case ea~h) , '~ .~ '  and 5.21 The 
other translocations mentioned as lp+ or lq+I6,I7 prob- 
ably represent translocations of uriidentified material onto 
the arms. 
Isochromosomes of both the long and short arms were 
observed commonly in 34 and 20 cases, respectively. Both 
markers have been reported in cervical cancer, isochro- 
mosomes of the long arm being more f r e q ~ e n t . ' ~ ~ ' ~ , ' ~ . ~ ~  
In other tumors, short arm isochromosomes are relatively 
rare. In contrast, i( 19) is a common nonrandom karyo- 
typic change in solid tumors32 and also has been observed 
in le~kemia.~' Among solid tumors, i(1q) was common 
to tumors of the breast,32 ovary,31,35-37 blad- 
der,38,39 and melanomas.40 The other markers also were 
observed in other malignancies, but in lower frequencies.26 
In a number of cases, more than one chromosome 1 
marker was present. Up to 11 markers were observed in 
some cases. In 21 cases, at least one of the markers was 
present in duplicate. Interestingly, 15 of these cases were 
hyperploid, indicating that in these cases chromosomal 
doubling had probably taken place after the tumor stem- 
line evolved with subsequent loss of some of the other 
duplicated markers. In a majority of the tumors, however, 
the marker chromosomes seem to have appeared after the 
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neoplastic stemline had undergone polyploidization. The 
coexistence of two normal chromosomes 1 with the 
marker chromosomes in some cases also suggests that the 
markers were formed after chromosomal doubling or cell 
replication in late S-phase or G2-phase. Selective endo- 
reduplication after establishment of the clone also may 
account for multiple copies of the same marker. 
The specificity with which certain bands and regions 
on chromosome 1 were involved in the structural aber- 
rations suggests that these sites contain genes whose loss 
or amplification is of importance in tumor development 
and/or maintenance. Although the number of published 
cases of cervical carcinoma is ~ m a l l , ' ~ - ~ '  taken together, 
the bands affected more than once are p32 in two cases 
and q21 (n = 7), q12 (n = 3), q32 (n = 3), q25 (n = 2), 
q3 1 (n = 2) on the long arm, and the centromeric region 
(n = 2). All of these bands were the site of nonrandom 
breaks in our cases (Fig. 2). In addition, they correlate 
well with the survey of breakpoints on chromosome 1 by 
Brito-Babapulle and Atkin3' in various other malignancies 
in which the centromeric region was primarily affected 
with smaller clusters of breaks at bands 1q31-32, lp22- 
p32, and p36. This again stresses the instability of partic- 
ular regions on chromosome 1 and their predisposition 
to rearrangement. 
Certain segments on the chromosome were retained or 
present in excess, and this may vary for different neo- 
plasms. For instance, Rowley4' observed consistent du- 
plication of bands lq25-q32 in a series of patients with 
various hematologic disorders. However, Gahrton et u Z . , ~ *  
summarizing abnormalities of chromosome 1 in myelo- 
proliferative disorders, noticed duplication of region 
lq23-q25. Kakati et u Z . , ~  and K o ~ a c s ~ ~  each reported 
over-representation of bands 1 q2 1 -q25 in various solid 
tumors. In our analysis, we observed that region lq2 1 - 
q32 was present consistently in 94% of the structural rear- 
rangements involving chromosome 1 (Fig. 3), either as 
short arm deletions, translocations, or isochromosomes. 
In addition, a specific region on the short arm ( 1 p 1 1 -p 1 3 
in 84%) was present nonrandomly. The delineation of 
these critical regions and bands specifically rearranged 
may enhance the possibility of localizing oncogenes as- 
sociated With cervical cancer. 
The nonrandomness of chromosome 1 involvement in 
human cervical carcinoma is of special importance be- 
cause five oncogenes have been mapped to this chromb- 
some. The oncogenes B-Lym- 1 and L-myc have been lo- 
calized to band 1p32,43,44 N-rus has been assigned to band 
lpl  I - ~ l 2 , ~ ~  c-src to 1p34-~36,~~ and c-ski to 1q22-q24.47 
Nine fragile sites glso have been located on chromosome 
1 (lp36, lp32, lp31.2, lp22, lp21.2, lq21.3, lq25.1, 
lq42, and lq44. l).48 In addition, genes for nucleic acid 
synthesis are localized on lq.49 All of the above oncogene 
sites and fragile sites are located at bands or regions fre- 
quently involved in the aberrations (Fig. 2). However, 
whether or not these oncogenes have a role in the trans- 
formation and progression of cervical carcinoma remains 
tb be determined. A correlative study of oncogene activity 
at the molecular level might help to verify the role of 
nonrandom structural chromosome changes in neoplasia. 
Much evidence has accumulated for an association be- 
tween herpes simplex virus (HSV) and carcinoma of the 
c e r ~ i x . ~ ' - ~ ~  HSV have been known to induce chromosome 
damage.55.56 A study by Mincheva et u Z . , ~ ~  on the effects 
of HSV strains on human fibroblast and lymphocyte 
chromosomes by banding showed that the most frequent 
aberrations were localized in bands p32, p34, q21, and 
q32 of chromosome 1 and band q21 of chromosome 3. 
This is of interest because all four bands on chromosome 
1 represent sites specifically altered in structural aberra- 
tions, particularly band lq32 that was involved in 88 
rearrangements. A subsequent report by the same 
authors5* showed additional damage at bands lp22, lq25, 
and lq42 by a temperature-sensitive mutant. These bands 
are again nonrandom sites of breakage. Studies on the 
effect of adenovirus 12 on cultured human cells led to 
recognition of the same bands 1 p32,l p36,l q42, and 1 q 12 
as sites of chromosome damage.59 The preferential damage 
of these sites suggest that these areas are susceptible to 
aberration or that they are of etiologic significance. 
To summarize, cancer is a multistep process and cancer 
progression is a complex secondary phenomenon that may 
involve a multitude of genes located in different chro- 
mosomes.60 Cytogenetically, this may manifest as in- 
creased chromosomal heterogeneity, and although these 
secondary changes may be extensive, the involvement of 
certain chromosomes or segments of chromosomes may 
be nonrandom. The fact that chromosome 1 is reported 
to be affected in a variety of tumors suggests that chro- 
mosome 1 changes may play a role in the evolution of all 
types of malignancy25 by conferring the tumor with a pro- 
liferative advantage, aiding in the maintenance of the tu- 
mor, or contribting to its resistance to therapy. In our 
study, the superimposition of other chromosomal alter- 
ations in all of the cases makes it difficult to ascertain 
whether they represent the initial cytogenetic event. The 
presence of chromosome 1 aberrations in early malig- 
nancy or premalignant lesions as in cervical cancers, l4,I5 
however, suggests that this might constitute an initiating 
event with maintenance of the premalignant state and 
subsequent progression to the invasive form of the cancer. 
Analysis of more cases of CIS with banding may clarify 
the role of chromosomes in early malignancy, as may also 
the blending of results obtained with molecular biologic 
techniques and cytogenetic methods. The use of DNA 
probes and restriction enzymes for gene mapping may 
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soon provide more information to define the precise con- 
tribution of specific chromosome abnormalities to on- 
cogenesis and tumor 
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